Keith T. Flaherty
0000-0002-3402-0478
Publication & Citation Trends
Publications
1,731 total
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.
Cited by 0
Semantic Scholar
Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis
Cited by 0
Semantic Scholar
Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death.
Cited by 0
Semantic Scholar
SIOG2024-4-P-124* Development of a new patient reported outcome to assess depression in older adults with cancer: preliminary psychometric properties
Cited by 0
Semantic Scholar
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment OA
Cited by 0
Semantic Scholar
MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies.
Cited by 9
Semantic Scholar
Abstract P117: Oncogenic Kit induces replication stress and induces Chk1/ATR inhibitor sensitivity in melanoma
Cited by 0
Semantic Scholar
Author Correction: From genes to drugs: targeted strategies for melanoma OA
Cited by 0
Semantic Scholar
Dermatology Research OA
Cited by 1
Semantic Scholar
Research Topics
Melanoma and MAPK Pathways
(822)
Cancer Immunotherapy and Biomarkers
(235)
Cutaneous Melanoma Detection and Management
(210)
CAR-T cell therapy research
(203)
Cancer Genomics and Diagnostics
(162)
Affiliations
The Wistar Institute
Broad Institute
Boston University
Brigham and Women's Hospital
Novartis (Switzerland)